Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Current assets:    
Cash and cash equivalents $ 5,856 $ 9,013
Marketable securities 252 3,835
Accounts receivable, net of allowance for doubtful accounts of $934 and $947 at January 31, 2021 and January 31, 2020, respectively 6,050 12,127
Unbilled receivables 9,359 14,279
Prepaid expenses and other current assets 4,372 5,112
Total current assets 25,889 44,366
Property and equipment, net 605 554
Operating lease right-of-use assets 4,968 4,860
Marketable securities   782
Intangible assets, net 1,272 2,300
Goodwill 10,577 9,775
Unbilled receivables 6,340 9,031
Other assets 757 1,222
Total assets 50,408 72,890
Current liabilities:    
Accounts payable 1,825 4,007
Accrued expenses 4,277 7,986
Deferred revenue 4,737 5,041
Promissory note 1,340  
Total current liabilities 12,179 17,034
Deferred revenue 657 1,140
Operating lease liabilities 4,070 4,348
Taxes payable 763 436
Promissory note 1,073  
Other liabilities 125  
Total liabilities 18,867 22,958
Commitments and contingencies (Note 8)
Stockholders' equity:    
Common stock, $0.01 par value; 100,000,000 shares authorized at January 31, 2021 and January 31, 2020; 37,811,224 shares issued and 37,639,304 shares outstanding at January 31, 2021; 37,303,952 shares issued and 37,163,462 outstanding at January 31, 2020 378 373
Additional paid-in capital 246,446 245,067
Treasury stock, at cost; 171,920 shares at January 31, 2021 and 140,490 shares at January 31, 2020 (227) (147)
Accumulated other comprehensive loss (73) (2,137)
Accumulated deficit (214,983) (193,224)
Total stockholders' equity 31,541 49,932
Total liabilities and stockholders' equity $ 50,408 $ 72,890